Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy R Chapman

Showing results (21-30 of 200) with videos related to

Pageof 20
Sort By:
Transplantation Research|February 26, 2014
What are the key challenges we face in kidney transplantation today?Jeremy R Chapman
The Lancet. Oncology|August 24, 2016
Cancer in patients with inherited ciliopathies: polycystic kidney diseaseJeremy R Chapman, Germaine Wong
Polskie Archiwum Medycyny Wewnetrznej|June 23, 2010
The KDIGO review of the care of renal transplant recipientEdward Tai, Jeremy R Chapman
Transplantation Reviews (Orlando, Fla.)|July 18, 2008
Cancers after renal transplantationGermaine Wong, Jeremy R Chapman
The Medical Journal of Australia|September 14, 2018
Kidney donation and transplantation in Australia: more than a supply and demand equationJeremy R Chapman, John Kanellis
The Medical Journal of Australia|September 5, 2006
Organ donation: a chance for Australia to do betterTimothy H Mathew, Jeremy R Chapman
Transplantation|May 10, 2005
The Global Alliance for TransplantationCarl G Groth, Jeremy R Chapman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2006
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?Jeremy R Chapman, Brian J Nankivell
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
Cancer after renal transplantation: the next challengeJeremy R Chapman, A C Webster
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 2, 2010
Why do patients develop proteinuria with sirolimus? Do we have the answer?Jeremy R Chapman, Gopala K Rangan
Pageof 20

Showing results (21-30 of 200) with videos related to

Sort By:
Pageof 20
Transplantation Research|February 26, 2014
What are the key challenges we face in kidney transplantation today?Jeremy R Chapman
The Lancet. Oncology|August 24, 2016
Cancer in patients with inherited ciliopathies: polycystic kidney diseaseJeremy R Chapman, Germaine Wong
Polskie Archiwum Medycyny Wewnetrznej|June 23, 2010
The KDIGO review of the care of renal transplant recipientEdward Tai, Jeremy R Chapman
Transplantation Reviews (Orlando, Fla.)|July 18, 2008
Cancers after renal transplantationGermaine Wong, Jeremy R Chapman
The Medical Journal of Australia|September 14, 2018
Kidney donation and transplantation in Australia: more than a supply and demand equationJeremy R Chapman, John Kanellis
The Medical Journal of Australia|September 5, 2006
Organ donation: a chance for Australia to do betterTimothy H Mathew, Jeremy R Chapman
Transplantation|May 10, 2005
The Global Alliance for TransplantationCarl G Groth, Jeremy R Chapman
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 27, 2006
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?Jeremy R Chapman, Brian J Nankivell
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2004
Cancer after renal transplantation: the next challengeJeremy R Chapman, A C Webster
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 2, 2010
Why do patients develop proteinuria with sirolimus? Do we have the answer?Jeremy R Chapman, Gopala K Rangan
Pageof 20